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ABSTRACT
The conserved PAF1 complex (Cdc73, Paf1, Ctr9,
Leo1 and Rtf1, in yeast), binds RNA pol II, and af-
fects levels of many RNAs. Although PAF1 is a com-
plex, there is evidence that different components per-
form different functions. In yeast, Cdc73, Paf1 and
Ctr9 maintain normal telomerase RNA (TLC1) levels
and affect telomere length. Here we report a new
connection between the PAF1 complex and telom-
ere biology. We show that Paf1 and Ctr9 maintain
low telomere repeat containing RNA (TERRA) levels
while Cdc73, Leo1 and Rtf1 have lesser effects. Anal-
ysis of double mutants shows that Paf1 and Ctr9 can
affect TERRA independently of Sir4, Rat1, and Trf4,
previously identified regulators of TERRA. The data
suggest that Paf1 and Ctr9 maintain low TERRA lev-
els by affecting both transcription and degradation
and that short telomeres in cdc73Δ, paf1Δ and ctr9Δ
mutants do not induce TERRA. These data estab-
lish the PAF1 complex as a new regulator of TERRA,
and are consistent with the model in which Paf1 and
Ctr9, the core components of the PAF1 complex, af-
fect transcript levels and cell fitness by numerous
mechanisms.
INTRODUCTION
Cdc73, Paf1, Ctr9, Leo1 and Rtf1 are components of the
PAF1 complex in yeast, a transcription elongation factor
(TEF), that binds RNA pol II (Figure 1A) and affects RNA
levels via a number of routes, transcriptional and post-
transcriptional (1–3). The PAF1 complex regulates histone
modifications, promoter-proximal pausing of RNA pol II,
transcript initiation, elongation, termination, polyadeny-
lation, nuclear export and RNA stability (1,2,4–9). Per-
haps not surprisingly, given its numerous roles, there is evi-
dence that the PAF1 complex affects RNA levels both posi-
tively and negatively (3,8). Recently, the PAF1 complex was
shown to function with the DNA damage response protein,
Mec1 and the INO80 chromatin remodelling complex, to
evict RNA pol II from chromatin, to help avoid collisions
between DNA replication forks and transcription machin-
ery (10).
Evidence from mammalian and yeast cells suggests that
different subunits of the PAF1 complex perform different
functions. For example, in mouse muscle cells, Rtf1 is miss-
ing from the PAF1 complex and is replaced by Ski8, an
adaptor for the cytoplasmic exosome (11). In yeast, paf1Δ
and ctr9Δ cells are comparatively unfit while cdc73Δ, leo1Δ
and rtf1Δ cells are fit, showing that Paf1 and Ctr9 are
more important for cell function than Cdc73, Leo1 and
Rtf1 (12,13). Also in yeast, cdc73Δ, paf1Δ and ctr9Δ cells
have short telomeres due to low levels of TLC1, the RNA
component of telomerase, while leo1Δ and rtf1Δ cells have
comparatively normal length telomeres and TLC1 levels
(13,14). Finally, human CDC73 and CTR9 genes are fre-
quently found mutated in cancer, and are the only PAF1
complex genes to be currently classified as tumour suppres-
sors (15,16).
Interestingly, the poor fitness of paf1Δ and ctr9Δ yeast
cells seems to be partially due to defective telomeres (13).
This was concluded because overexpression of TLC1 im-
proved the fitness of paf1Δ and ctr9Δ cells and partially
rescued the telomere length defects of these cells (13). How-
ever, the question remains as to why cdc73Δ cells, which
have equally low TLC1 levels and short telomeres as paf1Δ
or ctr9Δ cells, are comparatively fit.
We hypothesized that PAF1 complex components might
affect levels of other telomere-related factors that con-
tribute to cell fitness. Telomeric repeat containing RNA
(TERRA) is, like TLC1, a noncoding RNA that is impor-
tant at telomeres, and was a candidate for PAF1 complex
control. TERRA is observed in yeasts andmammalian cells
but its function and regulation are not fully understood.
TERRA is of biological significance because it can regulate
telomerase activity, promote recombination and activate
the DNA damage response (17–20). Additionally, TERRA
RNA:DNA hybrids at the telomere can stimulate homol-
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Figure 1. Paf1 andCtr9 repress TERRA levels. (A) A cartoon based on published structural data, estimating the locations of the PAF1 complex components
Cdc73, Paf1, Ctr9, Leo1 and Rtf1 on Pol II Elongation complex (12 subunit RNA pol II, TFIIS and Spt5) (3). Ctr9 acts as a bridge between Paf1-Leo1
and Cdc73 and does not strongly interact with RNA pol II, Rtf1 is flexible. Dashed lines indicate flexible regions. (B) TERRA from two independent
strains of each genotype was measured by two-step qRT-PCR. Each value was normalized to ACT1 mRNA and is indicated as fold change over WT.
Error bars represent average deviation. (C) One-step qRT-PCR analysis of TERRA in the strains indicated, as described in B. BUD6 mRNA was used as
the internal control (40). (D) Serial dilutions (5-fold) of saturated overnight cultures, grown at 23◦C, were spotted onto YEPD plates and incubated for 2
days at 23◦C. All strains were grown on a single plate but images, where indicated, have been cut and pasted to allow better comparisons. The spot tests
shown are representative of many replicate experiments. Strain numbers can be found in Table S1. Statistical analyses used the two-tailed unpaired T test
(*P < 0.05).
ogous recombination or G-quadruplex formation (17,21–
23). Interestingly, TERRA levels have been found to be
downregulated in telomerase-positive cancer cells, and up-
regulated in ALT-dependent cancer cells (24,25).
In yeast, TERRAdoes not have defined promoters or ter-
minators, and is a 5′ capped RNA pol II transcript, primar-
ily located in the nucleus (18,19). There are 32 telomeres
in budding yeast, with strong similarities but some struc-
tural differences, and the evidence is that TERRA from
each is regulated somewhat differently (26,27). TERRA can
be both polyadenylated and non-polyadenylated (18,28–
32). The transcription of TERRA is repressed, like other
telomeric transcripts, by the Sir complex, a histone deacety-
lase composed of Sir2, Sir3 and Sir4 (26,33). TERRA
is principally degraded by Rat1, the major nuclear 5′ to
3′ RNA exonuclease (18,19,26,31,34). In addition, there
is evidence that the TRAMP complex (Trf4/Air2/Mtr4p
Polyadenylation complex) promotes TERRA degradation
presumably in the 3′ to 5′ direction by the nuclear exosome
(18,19,26,31,34).
High TERRA levels have been associated with short
telomeres and vice versa (28,31,35,36). For example, in-
duction of TERRA transcription at a telomere specifically
shortened that telomere (36). Similarly, experimental short-
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ening of a single telomere, led to increased TERRA at
the same telomere (28). Since PAF1 components can affect
RNA pol II transcripts by numerous mechanisms, and af-
fect telomere length and cell fitness, it seemed plausible that
TERRA levels could be affected by the PAF1 complex.
Here we show that Paf1 and Ctr9, but not Cdc73, Leo1
or Rtf1, play an important role maintaining low TERRA
levels. High TERRA levels correlate with the poor fitness
of paf1Δ and ctr9Δ cells. Importantly, a number of exper-
iments show that Paf1 and Ctr9 are able to maintain low
TERRA levels through mechanisms that are independent
of the established mechanisms of TERRA regulation. Our
evidence suggests that Paf1 and Ctr9, the core components
of the PAF1 complex, affect TERRA levels transcription-
ally and post-transcriptionally.
MATERIALS AND METHODS
Yeast strain growth and transformation
Standard procedures for yeast culture, mating and tetrad
dissection were followed (37). Unless otherwise stated, all
experiments were performed using Saccharomyces cere-
visiae W303 (RAD5) strains. Consult S1 Table for strain
genotypes. YEPD was supplemented with adenine (75
mg/l). Gene disruptions were made using one step PCR
to insert kanMX or hphMX cassettes into the genome (38)
and confirmed by PCR. Primers and plasmids are listed (S2
and S3 Tables).
Yeast growth assays
A pool of colonies (>10) were grown in 2 ml liquid YEPD
or SC media overnight at 23◦C. 5-10-fold serial dilutions in
water were spotted onto round or rectangular agar plates
using a replica plating device. Plates were incubated for 2–
5 days at the appropriate temperatures before being pho-
tographed.
Analysis of telomere structure
Southern blot analysis was used to assess telomere length
as previously described (39). Genomic DNA was extracted,
digested with XhoI (Y’+TG and 15L probes) or HindIII
(10R, and 13R probes) and then run overnight on a 1%
agarose gel at 1 V/cm. Southern transfer was performed
using a Biorad Vacuum Blotter according to manufac-
turer’s indications. Probe labelling, hybridization and wash-
ingwere performed according to theDIGHigh PrimeDNA
Labelling andDetection Starter Kit II (Roche) instructions.
TheY’+TGprobe is approximately 1 kbwith∼880 bp of Y’
and 120 bp of TG repeats and is released from pDL1574 us-
ingXhoI andBamHI. The TEL10R, TEL13R andTEL15L
probes were made using primers indicated in Table S2. All
probes were gel-purified before being DIG-labelled (DIG
High Prime DNA Labelling and Detection Starter Kit II,
Roche) and probes TEL10R and TEL15L were also di-
gested with HaeIII prior to labelling, as suggested by the
manufacturer for long DNA fragments. Loading control
pictures were taken from each gel, before transfer, using
SYBR Safe DNA Gel Stain to stain the total DNA (lanes
were vertically compressed using Adobe Illustrator for pre-
sentation purposes).
Quantitative RT-PCR
In most cases two-step qRT-PCR experiments were per-
formed to measure TERRA. RNA was purified using the
RNEasy Mini Kit (Qiagen) with 3 DNAse I digestions
(first an ‘on-column’ digestion, then an ‘in solution’ and fi-
nally another ‘on-column’ digestion) using the RNase-Free
DNase Set (Qiagen). The first, cDNA synthesis step, was
performed exactly as published (26). In brief, 3 g of RNA
were reverse transcribed using a CA-rich primer (m4104),
which binds all telomeric repeats, and an ACT1-specific re-
verse primer (m4103), as a loading control. The second step,
qPCR of cDNA, was performed using forward and reverse
primers, directed to specific telomeres, with the Platinum
SYBR Green qPCR SuperMix-UDG with ROX (Invitro-
gen) kit in a final volume of 10 l. RNA measurements
were normalized relative to ACT1 mRNA levels, as previ-
ously described (26,40). The comparative 2–CT method
was used to plot the graphs relative to WT values as de-
scribed before (41).
RNA for one-step qRT-PCR analysis was isolated by
phenol essentially as described in (42), followed by further
purification using an RNEasyMini Kit and DNase I diges-
tion (Invitrogen). Next, one-step qRT-PCR was carried out
in the presence of forward and reverse primers, directed to
specific telomeres, using the Superscript III PlatinumSYBR
Green One-Step qRT-PCR kit (Invitrogen). RNAmeasure-
ments were normalized relative to BUD6 RNA, amplified
in a separate reaction as previously described (26,40).
For the measurement of polyadenylated TERRA, inde-
pendent cDNA synthesis reactions were performed using
either: (i) CA-rich andACT1-specific reverse primers; or (ii)
an Oligo(dT)15 primer (C1101, Promega). qPCR to detect
TERRA and polyadenylated TERRA used telomere spe-
cific forward primers and the CA-rich reverse primer. In ad-
dition, the cDNA synthesis step wasmodified as follows: af-
ter the 90◦C denaturation step, the samples were incubated
1 min at 42◦C, the enzyme mix was added and the sam-
ples were further incubated at 42◦C for 6.5 min (according
to Oligo(dT)15 manufacturer’s instructions). The extension
step was performed at 55◦C for 60 min.
RNA half-life determination
An anchor-away strain background (tor1–1 fpr1::NAT
RPL13A-2*FKBP12::TRP1 Rpb1-FRB-kanMX6) was
used to stop RNA pol II-mediated transcription upon
rapamycin addition (43). Briefly, Rpb1, the main subunit
of RNA pol II, is fused to the human FKBP12-rapamycin-
binding (FRB) domain of mTOR. FKPB12 is fused to
Rpl13a, a yeast ribosomal protein. Upon rapamycin
addition FRB and the FKBP12 domains interact and
the Rpb1 fusion is moved to the cytoplasm. For RNA
isolation, cell cultures were grown overnight at 30◦C until
early exponential phase (OD600 ∼ 0.5). A fraction of the
culture was harvested (0 min time-point) and rapamycin
was added (1 g/ml final concentration). Total RNA was
isolated from cells harvested at 0, 10, 20, 40 and 60 min
after rapamycin addition. RNA levels were measured for
each time-point and normalized for the amount of 7S
RNA. The amount of RNA is plotted (log2) as the fold
change in relation to the amount of RNA at time point 0.
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The slope (m) of the line that best fitted the data, ignoring
the 0 minute time point, was used to calculate the RNA
half-life using the equation T 1
2
= 0.693/m (26).
The transcription inhibitors 1,10-phenanthroline (100
mg/ml in 50% ethanol) or thiolutin (5 mg/ml in DMSO)
were used at final concentrations of 100 g/ml or 3
g/ml (44–46). RNA isolation and normalization was per-
formed as described above, for the anchor-away system. The
amount of RNA was plotted as the percentage of the RNA
levels observed at time point 0.
Statistical analyses
For qPCR and Southern blot measurements the mean of
the two independent strains is shown and the error bars, or
average deviation, represent the range of the two individual
values. Statistical analysis used the two-tailed unpaired t-
test (*P < 0.05, **P < 0.01 and ***P < 0.001).
Chromatin immunoprecipitation (ChIP)
ChIP was performed as previously described with the mi-
nor modification that formaldehyde crosslinking was per-
formed for 60 min (47). 3 g of mouse anti-FLAG (Sigma
F3165) or goat anti-mouse (Dako P0447) antibodies were
used per sample. Immunoprecipitated DNA was quantified
by qPCR using a SYBR Green qPCR SuperMIX-UDG
w/ROX kit (Invitrogen).
RESULTS
Paf1 and Ctr9 are needed for cell fitness and low TERRA
levels
Of the 32 telomeres in yeast, approximately half are X
telomeres, lacking the repetitive Y’ element found on the
remaining chromosome ends, and it is possible to generate
specific PCR primers to these ends. To determine whether
TERRA is affected in PAF1 complexmutants, wemeasured
TERRA transcribed from left-armX telomeres on chromo-
somes 1 and 15 (TEL01L and TEL15L), where TERRA
had previously been measured (26,36). Strikingly, paf1Δ
and ctr9Δ strongly increased TERRA, while cdc73Δ, leo1Δ
and rtf1Δ had smaller effects (Figure 1B, C).We confirmed,
as reported by others, that paf1Δ and ctr9Δ cells are com-
paratively unfit (deduced by size of colonies on agar plates),
while cdc73Δ, leo1Δ and rtf1Δ are fit (Figure 1D) (12).
Therefore, high TERRA levels in paf1Δ and ctr9Δ cells cor-
relate with the poor fitness of these mutants. Indeed, high
TERRA seems to correlate better with poor fitness than
low TLC1 levels because TLC1 levels are similarly low in
cdc73Δ, paf1Δ and ctr9Δ cells, but only paf1Δ and ctr9Δ
are noticeably unfit (Supplementary Figure S1 and Figure
1D).
To determine if Paf1 and Ctr9 affect polyadenylated
and non-polyadenylated TERRA similarly, total and
polyadenylated TERRA levels in paf1Δ and ctr9Δ cells
were measured using the method described in the scheme
in Supplementary Figure S2A. Polyadenylated and non-
polyadenylated TERRA are equally increased in paf1Δ and
ctr9Δ mutants (Supplementary Figure S2B). We estimate
that 7% of TERRA is polyadenylated, similar to the find-
ings in mammalian and Schizosaccharomyces pombe (Sup-
plementary Figure S2C) (30,32,48), but lower than previous
estimates in budding yeast rat1–1 mutants (31). We con-
clude that Paf1 and Ctr9 strongly repress polyadenylated
and non polyadenylated TERRA levels and that this effect
correlates with the poor fitness of paf1Δ and ctr9Δmutants.
Paf1 and Ctr9 regulate TERRA independently of telomere
length
Short telomeres have been associated with high TERRA
levels (20,28,31,36,49). However, cdc73Δ, paf1Δ and ctr9Δ
cells have similarly short telomeres, and low levels of TLC1,
but cdc73Δ cells have normal levels of TERRA in compari-
son with paf1Δ and ctr9Δ cells (Supplementary Figure S3B
and Figure 1B and C). To better understand the correla-
tion between telomere length and TERRA levels in cdc73Δ,
paf1Δ and ctr9Δ mutants, the lengths of specific telomeres
and TERRA levels from those same telomeres were exam-
ined from the same cultures. As controls, sir4Δ strains, pre-
viously reported to contain increased TERRA levels and
yku70Δ and mre11Δ strains with short telomeres were ex-
amined (26,28). At the same time, we tested the effects of
deleting CDC73 in paf1Δ and ctr9Δ cells, since Cdc73 is
required for the physical interaction of the PAF1 complex
with RNA pol II, and in Drosophila Cdc73 aids transcrip-
tion ofWnt target genes (2,25,31,50). This led us to hypoth-
esise that Cdc73 might be important for TERRA transcrip-
tion.
The effect of each mutation or mutations on TERRA
levels across four telomeres, TEL01L, TEL10R, TEL13R
and TEL15L, was measured (Figure 2B–E). As has
been reported before, the magnitude of the increase in
TERRA caused by specific mutations varied across telom-
eres (26,27). For example, sir4Δ caused a ten-fold increase
in TERRA from TEL01L but less than a three-fold in-
crease from TEL13R. Interestingly, TERRA levels were
similarly increased in paf1Δ, ctr9Δ and sir4Δ mutants, at
all telomeres examined. Furthermore, the effects of paf1Δ,
ctr9Δ and sir4Δ were stronger than the effects of yku70Δ
or mre11Δ at all telomeres. Finally, deletion of CDC73 in
paf1Δ or ctr9Δ cells did not decrease TERRA levels at
any telomere, showing that Cdc73 is not needed for high
TERRA levels in these contexts.
It was possible to generate comparatively specific South-
ern blot probes for TEL10R, TEL13R, TEL15L, but not
TEL01L. The effects of each mutation or mutations tested
on telomere length across these three telomeres were sim-
ilar to those observed on Y’ telomeres, using a standard
yeast telomere probe (Figure 2F). Overall, there was no
strong correlation between telomere length and TERRA
levels in cdc73Δ, paf1Δ, ctr9Δ,mre11Δ, sir4Δ and yku70Δ
cells. For example, cdc73Δ, paf1Δ, ctr9Δ cells had sim-
ilarly short TEL10R telomeres, but very different levels
of TERRA. Furthermore, mre11Δ and yku70Δ cells had
shorter telomeres than paf1Δ and ctr9Δ cells but lower
TERRA. Thus, our data suggest that short telomere length
does not strongly influence TERRA levels.
Our data suggest that Paf1 and Ctr9 repress TERRA in-
dependently of their effect on telomere length, yet previ-
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Figure 2. Lack of correlation between telomere length and TERRA levels in cells with stable telomeres. Two independent, exponentially-dividing strains
of each genotype were split and used to isolate RNA or DNA. (A) A map of single copy loci amplified during TERRAmeasurements (B-E) and Southern
blot probes (F). Distance from the centromeric end of the TG repeats is indicated. Primers used in the qRT-PCR and to make the probes are described in S2
Table. (B–E) TERRAmeasured as in Figure 1B. (F) Telomeric Southern blots performed after XhoI (top two gels) or HindIII (bottom two gels) digestion.
One membrane was first probed for telomere 15L and then Y’+TG sequences (Supplementary Figure S3A). The other membrane was first probed for
telomere 10R and finally 13R. Loading control corresponds to SYBR Safe staining of the gel probed for telomeres 10R and 13R.
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ous experiments have shown that telomere length affects
TERRA and vice versa. To further test the hypothesis
that Paf1 and Ctr9 are required to maintain low TERRA
levels independently of telomere length, we created ctr9Δ
and paf1Δ mutants with comparatively normal telomere
lengths. Consistent with what has been reported before,
overexpression of TLC1 largely rescued telomere length de-
fects of ctr9Δ and paf1Δ cells (Figure 3A, B, D, E) (13).
Importantly, ctr9Δ and paf1Δ cells with comparatively nor-
mal telomere length, had high TERRA levels (Figure 3C,
F). We conclude that Ctr9 and Paf1 regulate TERRA inde-
pendently of their effects on telomere length.
Paf1 and Ctr9 affect TERRA independently of Sir4
Since the effects of Paf1 and Ctr9 repressing TERRA
were as strong as Sir4 we speculated that Paf1/Ctr9 and
Sir4 function in the same pathway of TERRA regula-
tion. To test this, TERRA levels in sir4Δ paf1Δ and
sir4Δ ctr9Δ double mutants were assessed. Interestingly,
the sir4Δ paf1Δ and sir4Δ ctr9Δ double mutants had 4 to
8 times higher TERRA than the corresponding single mu-
tants from TEL01L, TEL10R and TEL15L (Figure 4A).
We conclude that Paf1 and Ctr9 maintain low TERRA lev-
els by a mechanism that is largely distinct to Sir4.
Paf1 and Rtf1 have been reported, like Sir4, to help si-
lence telomeric transcription (7). Therefore, it was plausible
that the PAF1 complex could contribute to low TERRA
by silencing telomeres through a parallel pathway to the Sir
complex (affecting histone methylation levels for instance).
To test this, URA3 expression was measured near a trun-
cated 7L telomere, often used to measure telomeric silenc-
ing (Figure 4B) (51,52). paf1Δ, ctr9Δ, rtf1Δ and sir4Δ cells
were unable to silence 7L while cdc73Δ and leo1Δ cells
were proficient at silencing (judged by growth on 5-FOA
plates) (Figure 4C and Supplementary Figure S4). These
results confirm and extend those previously reported (7).
Curiously, the sir4Δ mutation seemed to suppress the poor
growth fitness phenotype of paf1Δ and ctr9Δ cells, partic-
ularly at 34◦C (Supplementary Figure S4). We do not un-
derstand this observation but perhaps Sir4-regulated tran-
scripts contribute to the fitness of paf1Δ and ctr9Δ mu-
tants at high temperatures. Importantly, there was a clear
lack of correlation between telomere silencing in this assay
and TERRA expression (Figure 4C). In particular, rtf1Δ
cells were perhaps the most defective at silencing the trun-
cated 7L telomere (most similar to sir4Δ cells), but showed
very small effects on TERRA levels (Figure 1B, C). These
silencing assays suggested that PAF1 complex components
affected TERRA and silencing at least partially by different
mechanisms.
We were concerned that the lack of correlation between
7L silencing and TERRA levels was some type of artefact
of the artificial telomere used to measure silencing. The
truncated 7L telomere has lost a total of 16kb of telom-
eric DNA, including the X repeat, found on all normal
telomeres (Figure 4B). Furthermore, it is clear that paf1Δ
and ctr9Δ mutations strongly affect TERRA from X-only
telomeres (Figure 2) and telomere silencing is centred on the
X repeat (53,54). To more directly investigate the effects of
Paf1, Ctr9 and Rtf1, TERRA and telomere silencing were
measured at two natural telomeres. For this, TERRA tran-
scripts and transcripts from the opposite strand (ORF tran-
scripts) of TEL01L and TEL15L were measured. Interest-
ingly, and most clearly at the TEL01L, the mutations de-
repress TERRA levels to a greater extent than ORF tran-
script levels (Figure 4D). There was also a small increase of
the ORF transcript in paf1Δ and ctr9Δmutants, consistent
with a defect in telomere silencing. rtf1Δ, in contrast, af-
fected transcripts from both strands of TEL01L similarly,
consistent with rtf1Δ mutants showing a general telomere
silencing defect. sir4Δ, like rtf1Δ, affected transcripts from
both strands of TEL01L similarly, consistent with the sir4Δ
mutation causing a general telomere silencing defect, as ex-
pected. The silencing defect in sir4Δ mutants was greater
than in rtf1Δ mutants, consistent with truncated chromo-
some 7L silencing assays (Figure 4C, D). Analysis of tran-
scription from TEL15L revealed a broadly similar pattern,
although at this telomere it seemed that all mutations af-
fected TERRA more than transcription from the opposite
strand. The observation that Paf1 and Ctr9 show differen-
tial effects on telomeric RNA levels, depending on which
strand is transcribed, shows that Paf1 and Ctr9 are not si-
lencing all transcription near telomeres and suggests that
their effects on TERRA are mainly via a different mecha-
nism.
Paf1 promotes TERRA degradation
Since Paf1 and Ctr9 can regulate TERRA independently
of the Sir complex and telomere silencing, we hypothesized
that Paf1 and Ctr9 affected TERRA degradation. To test
this, the anchor-away system was used to remove the largest
RNA polymerase II subunit (Rpb1) from the nucleus upon
rapamycin addition. This stops transcription and permits
measurement of RNA decay rates (43). We observed that
the half-life of TERRA is similar to that of ACT1 and
BUD6, in wild type cells, as reported by others (Figure 5)
(26,55). The effect of paf1Δ on TERRA decay was clear,
dramatically increasing TERRAhalf-life (Figure 5, Supple-
mentary Figure S6). Interestingly, ACT1 and BUD6 RNA
half-lives also increased, but much less, 2–6-fold, suggesting
that Paf1 stimulates generalRNAdegradation andTERRA
degradation in particular.
During anchor-away strain construction we noticed that
paf1Δ cells were particularly unfit in the genetic back-
ground required for these experiments. Therefore, to con-
firm the paf1Δ effect on RNA stability, we used two com-
plementary approaches (56). 1,10-Phenanthroline, a metal
chelator, and thiolutin, a sulfur-containing antibiotic, have
been previously used to determine mRNA half-lives (57–
59). After 1,10-phenanthroline treatment TERRA from
TEL01L and TEL15L in paf1Δ mutants was higher than
in wild type and sir4Δ mutants, consistent with Paf1 play-
ing a role in TERRA degradation (Supplementary Figure
S7A). Interestingly, and consistent with the anchor-away ex-
periments, paf1Δ cells contained higher levels of ACT1 and
BUD6mRNA consistent with a role for Paf1 in degradation
of these transcripts too. After thiolutin treatment, TERRA
from TEL01L and TEL15L was stabilized in paf1Δ cells in
comparison to ACT1 RNA (Supplementary Figure S7B).
In summary, three different experimental approaches to
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Figure 3. Ctr9 and Paf1 regulate TERRA levels independently of telomere length. (A and D) ctr9Δ or paf1Δ heterozygous diploid cells were transformed
with a centromeric plasmid containing TLC1 or a vector. After sporulation, pairs of independent WT, ctr9Δ (A) and paf1Δ (D) haploid cells carrying
the TLC1 or vector plasmid were grown for 72 h at 23◦C on –URA liquid media, diluted (1:5000), grown overnight and DNA and RNA were extracted
when the cultures reached OD600 of 0.4–0.8. A telomere Southern blot using a Y’ + TG probe (as in Supplementary Figure S3) was performed. (B and
E) ImageJ was used to quantify the restriction fragment sizes of the gels in A or D. (C and F) TERRA measured as in Figure 1B. TERRA levels were
normalized to the mean of theWT cells with the vector, using ACT1 as an internal control. Statistical analyses used the two-tailed unpaired t-test (*P <
0.05, **P < 0.01 and ***P < 0.001).
measure RNA decay support the view that Paf1 and Ctr9
promote TERRA degradation.
Paf1, Rat1 and the TRAMP complex independently reduce
TERRA levels
Since Paf1 (and Ctr9) promote TERRA degradation it was
possible that Paf1 affected the Rat1 or nuclear exosome
pathways of degradation, or both (18,19,26,31).RAT1 is an
essential gene and therefore to test interactions with Rat1,
a temperature sensitive rat1–1 allele was combined with
paf1Δ and/or sir4Δmutations and cell fitness and TERRA
levelsmeasured. Interestingly, paf1Δ enhances the ts pheno-
type caused by rat1–1, suggesting, perhaps, that Paf1 facili-
tates Rat1 activity (Figure 6A). Furthermore, others have
reported that paf1Δ is synthetically sick with mutations
affecting RNA stability, suggesting Paf1 facilitates RNA
degradation (9). sir4Δ, in contrast, shows little synthetic fit-
ness interaction with rat1–1. Since paf1Δ and sir4Δ muta-
tions cause a similar increase in TERRA (Figure 6B), but
only the paf1Δ mutation is synthetically sick with rat1–1,
we conclude that synthetic sickness is not due simply to the
very high TERRA levels.
A previously established protocol was used to explore the
interactions betweenRat1 and Paf1 on TERRA levels. Cells
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Figure 4. Paf1 and Ctr9 affect telomere silencing but repress TERRA independently of the Sir complex. (A) qRT-PCR of TERRA as described in Figure
1B. (B) Map of URA3 integrated at the ADH4 locus and used to measure telomere silencing (51,52). (C) Silencing was measured by comparing growth on
plates lacking uracil (-URA), containing 5-Fluoro-orotic acid (5-FOA) or synthetic complete media (SC), at 23◦C. Additional strains and temperatures
are shown in Supplementary Figure S4. On the right, the relative effects of mutations on TERRA from telomere 1L (from Figure 1B and Figure 2B), are
indicated. (D) qRT-PCRof RNAs atYAL068W-A (telomere 1L) andYOL166W-A (telomere 15L) loci,was performed as described in Figure 1B. Dark grey
bars represent RNA transcribed in the direction from the telomere towards the centromere (ORF expression) and light grey bars represent transcription
in the opposite direction (TERRA). A scheme with the position of each ORF relative to the telomere end and the X element is underneath each graph. See
Supplementary Figure S5 for a more detailed explanation of the RNA measurements from TEL01L. Statistical analyses used two-tailed unpaired t-test
(*P < 0.05, **P < 0.01 and ***P < 0.001).
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Figure 5. Paf1 stabilizes TERRA and other RNAs. Two independent paf1Δ strains, and a singleWT strain (DLY11213/MP0455) cultured twice, carrying
the two fusion proteins Rpb1*FRB (Rpb1, part of RNA pol II; FRB, domain of human mTOR) and Rpl13a-FKBP12 (Rpl13a, ribosomal protein;
FKBP12, FK-506 binding protein) were treated with rapamycin. Rapamycin forms a ternary complex with FRB and FKBP12, leading to the removal
of Rpb1 from the nucleus [34]. RNA levels at different time points after rapamycin addition were used to calculate half-life. (A) qRT-PCR of 01L and
15L TERRA and ACT1, BUD6 after addition of rapamycin (each replicate and DMSO treatments are in Supplementary Figure S6). Data from two
independent strains are shown and the error bars represent average deviation. (B) Half-life (min) was calculated as described in Materials and Methods
using the slope of the lines in A. ‘∞’ is shown when no RNA decrease was observed over 60 min (a positive slope was observed). Fold changes (Fold) of
paf1Δ strains relative toWT are indicated.
were cultured for 90 min at 37◦C to inactivate Rat1–1 (31).
Under these conditions paf1Δ and sir4Δmutations affected
TERRA similarly but less than rat1–1 (Figure 6B, C). Previ-
ous data show that Rat1 and the Sir complex affect TERRA
through independent pathways (26) and our results con-
firm this (Figure 6B, C). The data also show that rat1–1
strongly increases TERRA levels in paf1Δ and paf1Δ sir4Δ
cells. Overall these data are consistent with the idea that
Paf1/Ctr9, Sir4 and Rat1 contribute independently to reg-
ulate TERRA levels.
There is evidence that the TRAMP complex facilitates
TERRA degradation in rat1–1 mutants, although no in-
crease in TERRA levels was seen in trf4Δ (defective in the
TRAMP complex) or rrp6Δ (defective in the nuclear exo-
some) single mutants (31). To test whether Paf1 and Ctr9
regulate TERRA through the TRAMP/exosome pathway
rrp6Δ and trf4Δ were deleted in ctr9Δ and paf1Δ mu-
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Figure 6. Evidence that Paf1 regulates TERRA levels independently of Rat1. Pairs of independent mutant strains, and a singleWT strain were cultured
overnight. (A) Spot tests as described in Figure 1D were performed. (B and C). Cell cultures used for A were diluted (1:5000) and when the OD600 was
between 0.5 and 0.7 the temperature was shifted from 23◦C to 37◦C for 90 min (31). TERRAmeasurements were performed as described in Figure 1B. The
average of two independent strains was normalized relative to theWT strain. Error bars represent average deviation. Statistical analyses used the two-tailed
unpaired T test (*P < 0.05 and ***P < 0.001).
tants. As previously reported, rrp6Δ cells did not show in-
creased TERRA and we did not see any synergistic increase
in TERRA levels of paf1Δ rrp6Δ or ctr9Δ rrp6Δ cells (Fig-
ure 7A, B). This suggests that the nuclear exosome has a
comparatively minor role in TERRA degradation. Interest-
ingly, a small but significant increase in TERRA levels was
observed in trf4Δ cells (Figure 7C, D). Consistent with the
idea that the TRAMP complex affects TERRA indepen-
dently of Paf1, paf1Δ trf4Δ cells have much higher levels
of TERRA than paf1Δ or trf4Δ cells (Figure 7C, D). We
conclude that the PAF1 complex regulates TERRA inde-
pendently of Trf4 (and theTRAMPcomplex). Additionally,
our data suggest that the TRAMP complex could promote
Rrp6(exosome)-independent TERRA degradation. Overall
the data suggest that Paf1 and Ctr9 can affect TERRA lev-
els independently of the known, Rat1- and Trf4-dependent,
pathways. One explanation for these data is that the Paf1
complex helps both Rat1 and Trf4 pathways to degrade
TERRA.
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Figure 7. Paf1 regulates TERRA independently of Trf4. (A–D) TERRA measurements were performed on two independent strains of each genotype as
described in Figure 1B and the mean is shown. Error bars represent average deviation. Statistical analyses used the two-tailed unpaired T test (*P < 0.05,
**P < 0.01 and ***P < 0.001).
Paf1 and Ctr9 localise at telomeres
One hypothesis for how Paf1 and Ctr9 affect TERRA levels
more than Cdc73, Leo1 or Rtf1, is that these are the only
two components that travel with RNA pol II to transcribe
TERRA. To test this hypothesis, we performed ChIP analy-
sis on Paf1, Ctr9 and Leo1. As controls, we also performed
ChIP on Rpb1, a subunit of RNA pol II (since the PAF1
complex associates with RNA pol II), Cdc13 (a telomere
binding protein) and Ndc10 (a centromere binding pro-
tein). As expected, Cdc13 strongly associated with telom-
ericDNAwhileNdc10 strongly associatedwith centromeric
DNA, showing specificity in these experiments (Figure 8).
In contrast, we found that Paf1, Ctr9, Leo1 and Rpb1 asso-
ciate both with telomeric (TEL01L, TEL06R, Y’3) and cen-
tromeric (CEN3)DNA (Figure 8). These data are consistent
with the idea that Paf1, Ctr9 and Leo1 are part of a single
TEF complex that transcribes telomeres and centromeres
and that the existence of different Paf1 sub-complexes is not
the explanation for the different effects of Paf1/Ctr9 versus
Leo1 on TERRA levels.
DISCUSSION
The Paf1 complex is conserved, binds RNA polymerase II,
and affects the abundance of many transcripts. Previous ex-
periments in yeast have connected components of the PAF1
complex with telomere functions. Specifically, Paf1, Ctr9
and Cdc73 have been reported to contribute to telomerase
template RNA expression and normal telomere length reg-
ulation (13). Here, we report that, of these, Paf1 and Ctr9,
but not Cdc73, are required to maintain low TERRA levels
(a conserved non-coding telomeric RNA found across eu-
karyotes from yeast to mammalian cells). Interestingly, loss
of Paf1 and Ctr9 also reduces cell fitness more than loss of
Cdc73. These observations show that high TERRA corre-
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andCEN3). ChIP was performed using either an anti-FLAG antibody or an anti-mouse IgG as a control. The amount of each locus precipitated is plotted
as percentage of input. Two independent strains for each of genotype were processed except for the Cdc13 and Ndc10 FLAG tagged strains where in each
case a single strain was cultured twice. The mean is shown and error bars represent average deviation. Protein molecular weight/levels, telomere length and
cell fitness of the new epitope tagged strains are shown in Supplementary Figure S8.
lates better with poor cell fitness across cells lacking Cdc73,
Paf1 or Ctr9, than low TLC1 levels.
There is a correlation between high TERRA levels
and poor fitness of paf1Δ and ctr9Δ mutants, suggest-
ing that TERRA or other dysregulated transcripts might
be toxic. One mechanism that might explain why high
TERRA itself, is toxic, is that in combination with
loss of Paf1/Ctr9 TERRA is particularly harmful. This
could be due to the role of the Paf1 complex in resolv-
ing transcription/replication fork collisions. paf1Δ cells
demonstrate slow replication-fork progression and in-
creased transcription–replication fork collisions, particu-
larly when RNA and DNA polymerases are travelling in
the same direction (10). At the telomere, RNA and DNA
polymerases travel in the same direction, toward the chro-
mosome end, and this, in combination with high levels of
TERRA, and therefore increased levels of RNA:DNA hy-
brids may be a particular issue for paf1Δ and ctr9Δ cells.
There are many reports that telomere length affects
TERRA and vice versa. However, Cdc73, Paf1 and Ctr9 all
have similar effects on telomere length but affect TERRA
to very different extents, showing that these proteins do not
seem to affect TERRA via affecting telomere length. Con-
sistent with this, when telomere length was normalized in
cells lacking Ctr9 or Paf1, TERRA levels remained high.
Thus, at least across cdc73Δ, paf1Δ and ctr9Δ cells there
is not a good correlation between TERRA and telomere
length, suggesting Paf1 and Ctr9 have more direct effects
on TERRA.
How the PAF1 complex affects TERRA is still not com-
pletely clear. The PAF1 complex affects the levels of many
transcripts, both positively and negatively, and therefore it
is possible that Paf1/Ctr9 might affect TERRA via a num-
ber ofmechanisms. paf1Δ strongly increased TERRA levels
in sir4Δ, rat1–1 and trf4Δ strains. On this basis, we cannot
assign Paf1/Ctr9 to just one of the three major pathways
of TERRA regulation (Sir4, Rat1 or Trf4-dependent). The
most logical explanation for these results is that Paf1 and
Ctr9 affect TERRA in many ways, transcriptionally and
post-transcriptionally, for example affecting Sir4, Rat1 or
Trf4-dependent pathways of TERRA regulation.
Our data, and recent structural data, are consistent with
a model where the entire PAF1 complex is stably associated
with Pol II and reaches the telomere (10). We suggest that
the Paf1 complex recruits other factors, such as nucleases
and histone methylases, to perform subunit-specific func-
tions and that loss of Paf1/Ctr9, the scaffolding proteins,
leads to the disruption of most PAF1-related functions and
that more than one of these functions affect TERRA lev-
els. Mutations in CDC73 and CTR9 have been identified in
cancer and telomere function is often affected in cancer. It
seems plausible that one of the ways that the PAF1 complex
affects human cancer is by affecting TERRA.
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